Herbert A. Lassiter

667 total citations
27 papers, 496 citations indexed

About

Herbert A. Lassiter is a scholar working on Immunology, Pediatrics, Perinatology and Child Health and Neurology. According to data from OpenAlex, Herbert A. Lassiter has authored 27 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 8 papers in Pediatrics, Perinatology and Child Health and 5 papers in Neurology. Recurrent topics in Herbert A. Lassiter's work include Neonatal and fetal brain pathology (7 papers), Complement system in diseases (7 papers) and Traumatic Brain Injury and Neurovascular Disturbances (5 papers). Herbert A. Lassiter is often cited by papers focused on Neonatal and fetal brain pathology (7 papers), Complement system in diseases (7 papers) and Traumatic Brain Injury and Neurovascular Disturbances (5 papers). Herbert A. Lassiter collaborates with scholars based in United States, Egypt and United Kingdom. Herbert A. Lassiter's co-authors include Pamela W. Feldhoff, Richard C. Feldhoff, Laura Gordon, Robert D. Christensen, David C. Hall, Harry R. Hill, Mark S. Brown, Jerome E. Tanner, S. W. Watson and Salvatore Bertolone and has published in prestigious journals such as PEDIATRICS, The Journal of Infectious Diseases and The Journal of Pediatrics.

In The Last Decade

Herbert A. Lassiter

25 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Herbert A. Lassiter United States 12 174 131 115 111 90 27 496
Mitsuru Tsuge Japan 13 106 0.6× 42 0.3× 90 0.8× 206 1.9× 23 0.3× 41 601
Jones Db United States 12 36 0.2× 62 0.5× 27 0.2× 54 0.5× 34 0.4× 40 573
Menachem Schlesinger Israel 17 358 2.1× 23 0.2× 22 0.2× 113 1.0× 26 0.3× 30 741
Irène Dunn-Siegrist Switzerland 13 454 2.6× 76 0.6× 26 0.2× 238 2.1× 18 0.2× 13 780
Paul Moriarty Ireland 16 38 0.2× 75 0.6× 60 0.5× 70 0.6× 11 0.1× 27 770
Vanesa Goméz-Piña Spain 13 471 2.7× 51 0.4× 17 0.1× 117 1.1× 54 0.6× 17 680
I. Soveral Spain 9 91 0.5× 32 0.2× 43 0.4× 299 2.7× 16 0.2× 18 656
Masato Yashiro Japan 14 124 0.7× 19 0.1× 19 0.2× 112 1.0× 39 0.4× 53 530
William D. Bradford United States 15 47 0.3× 33 0.3× 33 0.3× 95 0.9× 13 0.1× 28 463
R. Macaulay United Kingdom 10 517 3.0× 27 0.2× 20 0.2× 259 2.3× 68 0.8× 71 863

Countries citing papers authored by Herbert A. Lassiter

Since Specialization
Citations

This map shows the geographic impact of Herbert A. Lassiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert A. Lassiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert A. Lassiter more than expected).

Fields of papers citing papers by Herbert A. Lassiter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herbert A. Lassiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert A. Lassiter. The network helps show where Herbert A. Lassiter may publish in the future.

Co-authorship network of co-authors of Herbert A. Lassiter

This figure shows the co-authorship network connecting the top 25 collaborators of Herbert A. Lassiter. A scholar is included among the top collaborators of Herbert A. Lassiter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herbert A. Lassiter. Herbert A. Lassiter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aly, Hany, Mohamed Khashaba, Sheron C. Lear, et al.. (2005). Complement component 9 activation, consumption, and neuronal deposition in the post-hypoxic–ischemic central nervous system of human newborn infants. Neuroscience Letters. 378(1). 1–6. 23 indexed citations
2.
3.
Gordon, Laura, et al.. (2005). The administration of cobra venom factor reduces post-ischemic cerebral injury in adult and neonatal rats. Neuroscience Letters. 380(1-2). 48–53. 44 indexed citations
4.
Devlin, Lori A., et al.. (2005). Effects of endotoxin administration and cerebral hypoxia-ischemia on complement activity and local transcriptional regulation in neonatal rats. Neuroscience Letters. 390(2). 109–113. 6 indexed citations
5.
Devlin, Lori A. & Herbert A. Lassiter. (2004). Immunoenhancement to prevent nosocomial coagulase-negative staphylococcal sepsis in very low-birth-weight infants. Clinics in Perinatology. 31(1). 69–75. 3 indexed citations
6.
Lassiter, Herbert A.. (2004). The role of complement in neonatal hypoxic-ischemic cerebral injury. Clinics in Perinatology. 31(1). 117–127. 11 indexed citations
7.
Feldhoff, Pamela W., et al.. (2002). The administration of complement component C9 augments post-ischemic cerebral infarction volume in neonatal rats. Neuroscience Letters. 325(3). 175–178. 33 indexed citations
8.
Lassiter, Herbert A., et al.. (2001). Complement inhibition does not reduce post-hypoxic-ischemic cerebral injury in 21-day-old rats. Neuroscience Letters. 302(1). 37–40. 17 indexed citations
9.
Lassiter, Herbert A., et al.. (2001). Nonspecific Human IgG Reduces Survival in Neonatal Rats Infected with Escherichia coli. The American Journal of the Medical Sciences. 322(3). 141–144. 3 indexed citations
10.
Lassiter, Herbert A., et al.. (2000). Complement depletion with cobra venom factor reduces post-hypoxic-ischemic cerebral edema in neonatal rats. Journal of Investigative Medicine. 48(1). 152. 1 indexed citations
11.
Jung, Elizabeth, et al.. (1998). Complement Component C9 Enhances the Capacity of Beta-Lactam Antibiotics to Kill Escherichia coli In Vitro and In Vivo. The American Journal of the Medical Sciences. 315(5). 307–313. 3 indexed citations
12.
Lassiter, Herbert A., Jessica L. Wilson, Elizabeth Jung, et al.. (1997). The Administration of Complement Component C9 Enhances the Survival of Neonatal Rats with Escherichia coli Sepsis1. Pediatric Research. 42(1). 128–136. 23 indexed citations
13.
Lassiter, Herbert A., et al.. (1993). Neonatal Immune Neutropenia Following the Administration of Intravenous Immune Globulin. Journal of Pediatric Hematology/Oncology. 15(1). 120–123. 39 indexed citations
14.
Lassiter, Herbert A., et al.. (1992). Inefficient Bacteriolysis of Escherichia coli by Serum from Human Neonates. The Journal of Infectious Diseases. 165(2). 290–298. 13 indexed citations
15.
Lassiter, Herbert A., et al.. (1992). Complement Factor 9 Deficiency in Serum of Human Neonates. The Journal of Infectious Diseases. 166(1). 53–57. 39 indexed citations
16.
Christensen, Robert D., Mark S. Brown, David C. Hall, Herbert A. Lassiter, & Harry R. Hill. (1991). Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune globulin to neonates with clinical signs of early-onset sepsis. The Journal of Pediatrics. 118(4). 606–614. 63 indexed citations
17.
Lassiter, Herbert A., et al.. (1991). DIMINSHED IGG, BUT NOT COMPLEMENT C3 OR C4 OR FACTOR B, PRECEDES NOSOCOMIAL BECTERIAL SEPSIS IN VERY LOW BIRTH WEIGHT NEONATES. The Pediatric Infectious Disease Journal. 10(9). 663–667. 11 indexed citations
18.
Lassiter, Herbert A., R D Christensen, & Charles J. Parker. (1989). Immunologic Regulation of E. coli K1 by Serum from Neonatal Rats is Enhanced Following Intraperitoneal Administration of Human IgG. The Journal of Infectious Diseases. 159(3). 518–525. 4 indexed citations
19.
Lassiter, Herbert A., et al.. (1988). Neutrophil-Mediated Killing, Opsonization, and Serum-Mediated Killing of <i>Escherichia coli</i> K1 by Neonatal Rats. Neonatology. 53(3). 156–162. 11 indexed citations
20.
Lassiter, Herbert A.. (1980). Neonatal Hyperthyroidism With Conjugated Hyperbilirubinemia. Southern Medical Journal. 73(4). 501–503.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mitsuru Tsuge Breakdown of academic impact, for papers by Jones Db Breakdown of academic impact, for papers by Menachem Schlesinger Breakdown of academic impact, for papers by Irène Dunn-Siegrist Breakdown of academic impact, for papers by Paul Moriarty Breakdown of academic impact, for papers by Vanesa Goméz-Piña Breakdown of academic impact, for papers by I. Soveral Breakdown of academic impact, for papers by Masato Yashiro Breakdown of academic impact, for papers by William D. Bradford Breakdown of academic impact, for papers by R. Macaulay
Rankless by CCL
2026